Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52‐Week, Randomized, Controlled Trial

OBJECTIVE: To evaluate the effect of ixekizumab on self‐reported functioning and health in patients with active nonradiographic axial spondyloarthritis (SpA). METHODS: COAST‐X was a randomized, controlled trial conducted in patients with nonradiographic axial SpA over 52 weeks. Participants were ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Jessica A., Magrey, Marina N., Baraliakos, Xenofon, Inui, Kentaro, Weng, Meng‐Yu, Lubrano, Ennio, van der Heijde, Désirée, Boonen, Annelies, Gensler, Lianne S., Strand, Vibeke, Braun, Jürgen, Hunter, Theresa, Li, Xiaoqi, Zhu, Baojin, León, Luis, Calderon, David Marcelino Sandoval, Kiltz, Uta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306696/
https://www.ncbi.nlm.nih.gov/pubmed/33044756
http://dx.doi.org/10.1002/acr.24482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306696/
https://www.ncbi.nlm.nih.gov/pubmed/33044756
http://dx.doi.org/10.1002/acr.24482

Ejemplares similares